30 min listen
Fine-Tuning Chronic Lymphocytic Leukemia Management: Optimising Bruton Tyrosine Kinase Inhibitor Use in Practice
FromKeeping Current
Fine-Tuning Chronic Lymphocytic Leukemia Management: Optimising Bruton Tyrosine Kinase Inhibitor Use in Practice
FromKeeping Current
ratings:
Length:
35 minutes
Released:
May 30, 2024
Format:
Podcast episode
Description
What are the latest advances shaping chronic lymphocytic leukemia (CLL) treatment today? Discover the role of Bruton tyrosine kinase (BTK) inhibitors through our expert-led journey. Credit available for this activity expires: 5/29/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1001127?ecd=bdc_podcast_libsyn_mscpedu
Released:
May 30, 2024
Format:
Podcast episode
Titles in the series (100)
The AxSpA Spectrum of Diseases: How to Diagnose and Manage Patients in Clinical Practice?: Learn about the key clinical signs and symptoms for the diagnosis of AxSpA and potential treatment strategies. --- Full URLs: Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/927260?src=mkm_podcast_addon_927260 by Keeping Current